Curaleaf Keeps Aurora Bid Open After Rival Organigram Deal
Curaleaf Holdings announced on November 3, 2026 that its enhanced takeover offer for Aurora Cannabis remains outstanding after Aurora agreed to a competing acquisition by Organigram Global . The rival transaction offers C$7.80 per Aurora common share and values Aurora at approximately C$561 million on a fully diluted equity basis. Organigram and Aurora’s joint announcement says both companies’ boards unanimously approved their arrangement. The companies calculate that the consideration…